Focal/Grid Photocoagulation vs. Intravitreal Triamcinolone for Treatment of Diabetic Macular Edema

March 12, 2009

The March 2009 issue of The Archives of Ophthalmology contains a report on the 3-year outcomes of patients who participated in a randomized trial evaluating 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone compared with focal/grid photocoagulation for treatment of diabetic macular edema.

Eyes with diabetic macular edema and visual acuities of 20/40 to 20/320 were randomly assigned to focal/grid photocoagulation or 1 mg or 4 mg of triamcinolone. At the conclusion of the trial, 3-year follow-up data were available in 306 eyes.

Results did not indicate a long-term benefit of intravitreal triamcinolone relative to focal/grid photocoagulation in patients with diabetic macular edema.

Read the full report.




Jump down to form below to submit your own comments

Trackback URL

Have insights to contribute? Please submit your comment below